BM&FBOVESPA today began trading 19 new Unsponsored Level I BDR programs (BDR NP), issued by Deutsche Bank SA PN. BDRs are securities issued in Brazil by depository institutions and which have shares of foreign companies as underlying.

They are traded on the cash market from 10:00 a.m.to 5:00 p.m., with round lots of 100 BDRs. The new programs authorized for trading from today are for BDRs with shares of the following companies as underlying:

Company BDR Ticker
ABBVie Inc. ABBV34
Biogen Inc. BIIB34
BlackRock, Inc. BLAK34
Cognizant Technology Solutions CTSH34
Costco Wholesale Corporation COWC34
CVS Health Corporation CVSH34
Delta Air Lines, Inc. DEAI34
E.I. du Pont de Nemours and Company DUPO34
EMC Corporation EMCC34
Express Scripts Holding Company ESRX34
Gilead Sciences, Inc. GILD34
Macy's, Inc. MACY34
Medtronic Public Limited Company MDTC34
Ross Stores, Inc. ROST34
Salesforce.com, Inc. SSFO34
The Charles Schwab Corporation SCHW34
The Gap, Inc. GPSI34
The Travelers Companies, Inc. TRVC34
Thermo Fisher Scientific Inc. TMOS34

The BDR NP program
The Unsponsored Level I BDR program (BDR NP) is an important BM&FBOVESPA initiative that aims to expand the portfolio of listed products. With this launch, the BDR NP portfolio now contains 104 programs. For the investor, the product is an alternative for expanding the range of exposure in the international market, with the possibility of developing strategies, investment diversification and arbitrage between local and foreign assets.

More information about the product here.

BM&FBovespa SA issued this content on 25 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 25 April 2016 21:17:36 UTC

Original Document: http://www.bmfbovespa.com.br/en_us/news/unsponsored-level-i-bdr.htm